Applied Therapeutics (APLT) News Today $9.01 +0.09 (+1.01%) (As of 05:19 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Applied Therapeutics (NASDAQ:APLT) Hits New 12-Month High - Time to Buy?Applied Therapeutics (NASDAQ:APLT) Sets New 12-Month High - Time to Buy?November 11 at 9:44 AM | marketbeat.comApplied Therapeutics Advances with Govorestat ApprovalsNovember 9, 2024 | markets.businessinsider.comApplied Therapeutics (APLT) Gets a Buy from RBC CapitalNovember 9, 2024 | markets.businessinsider.comApplied Therapeutics, Inc. (NASDAQ:APLT) Receives Consensus Rating of "Buy" from AnalystsApplied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six brokerages that are presently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and one has issued aNovember 8, 2024 | marketbeat.comApplied Therapeutics (APLT) Gets a Buy from William BlairNovember 8, 2024 | markets.businessinsider.comApplied Therapeutics to Present at the 2024 UBS Global Healthcare ConferenceNovember 5, 2024 | finance.yahoo.comApplied Therapeutics (NASDAQ:APLT) Sets New 12-Month High - Here's WhyApplied Therapeutics (NASDAQ:APLT) Reaches New 1-Year High - Should You Buy?November 4, 2024 | marketbeat.comApplied Therapeutics, Inc. (NASDAQ:APLT) Short Interest UpdateApplied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 14,530,000 shares, a growth of 17.6% from the September 30th total of 12,360,000 shares. Based on an average trading volume of 2,510,000 shares, the days-to-cover ratio is currently 5.8 days.October 28, 2024 | marketbeat.comHennion & Walsh Asset Management Inc. Raises Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT)Hennion & Walsh Asset Management Inc. lifted its holdings in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 34.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 265,372 shares of the company's stock after purchOctober 26, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Down 4.9% - What's Next?Applied Therapeutics (NASDAQ:APLT) Stock Price Down 4.9% - Here's What HappenedOctober 25, 2024 | marketbeat.comApplied Therapeutics call volume above normal and directionally bullishOctober 25, 2024 | markets.businessinsider.comApplied Therapeutics put volume heavy and directionally bearishOctober 24, 2024 | markets.businessinsider.comWilliam Blair Issues Pessimistic Estimate for APLT EarningsApplied Therapeutics, Inc. (NASDAQ:APLT - Free Report) - William Blair decreased their Q2 2025 earnings per share (EPS) estimates for Applied Therapeutics in a report released on Tuesday, October 22nd. William Blair analyst L. Hanbury-Brown now forecasts that the company will earn ($0.11) per shaOctober 24, 2024 | marketbeat.comWilliam Blair Reaffirms Their Buy Rating on Applied Therapeutics (APLT)October 22, 2024 | markets.businessinsider.comApplied Therapeutics (NASDAQ:APLT) Trading Down 2.2% - Here's What HappenedApplied Therapeutics (NASDAQ:APLT) Stock Price Down 2.2% - Time to Sell?October 16, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Up 6.4% - Should You Buy?Applied Therapeutics (NASDAQ:APLT) Trading Up 6.4% - Time to Buy?October 14, 2024 | marketbeat.comApplied Therapeutics, Inc. (NASDAQ:APLT) Sees Significant Growth in Short InterestApplied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 12,360,000 shares, a growth of 14.2% from the September 15th total of 10,820,000 shares. Based on an average trading volume of 2,390,000 shares, the short-interest ratio is currently 5.2 days.October 14, 2024 | marketbeat.comApplied Therapeutics, Inc. (NASDAQ:APLT) Receives Average Rating of "Buy" from BrokeragesApplied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) has earned a consensus recommendation of "Buy" from the six ratings firms that are covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recoOctober 14, 2024 | marketbeat.comSei Investments Co. Invests $535,000 in Applied Therapeutics, Inc. (NASDAQ:APLT)Sei Investments Co. purchased a new stake in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 114,619 shares of the company's stock, valued at approxOctober 10, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Trading 6.6% Higher - What's Next?Applied Therapeutics (NASDAQ:APLT) Shares Up 6.6% - Time to Buy?October 8, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Shares Down 5.7% Applied Therapeutics (NASDAQ:APLT) Shares Down 5.7%October 3, 2024 | marketbeat.comLogos Global Management LP Lowers Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT)Logos Global Management LP reduced its position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 55.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 600,000 shares of the coOctober 1, 2024 | marketbeat.comPerceptive Advisors LLC Has $37.38 Million Position in Applied Therapeutics, Inc. (NASDAQ:APLT)Perceptive Advisors LLC cut its holdings in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 5.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 8,005,000 shares of the company's stock after selling 500,000 shares during the quarter. Perceptive AdvSeptember 30, 2024 | marketbeat.comApplied Therapeutics, Inc. (NASDAQ:APLT) Sees Large Growth in Short InterestApplied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 10,820,000 shares, an increase of 10.7% from the August 31st total of 9,770,000 shares. Based on an average daily trading volume, of 2,380,000 shares, the days-to-cover ratio is presently 4.5 days.September 29, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Increases Stock Position in Applied Therapeutics, Inc. (NASDAQ:APLT)Frazier Life Sciences Management L.P. boosted its stake in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 17.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,286,135 shares of the company'September 29, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Stock Price Up 5.2%Applied Therapeutics (NASDAQ:APLT) Shares Up 5.2%September 25, 2024 | marketbeat.comRhumbline Advisers Buys 133,351 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)Rhumbline Advisers grew its stake in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 24,513.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 133,895 shares of the company'September 25, 2024 | marketbeat.comLogos Global Management LP Sells 750,000 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)Logos Global Management LP decreased its position in Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) by 55.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 600,000 shares of tSeptember 24, 2024 | marketbeat.comQ2 2025 Earnings Forecast for Applied Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:APLT)Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) - Research analysts at Leerink Partnrs boosted their Q2 2025 earnings per share estimates for Applied Therapeutics in a research note issued to investors on Wednesday, September 18th. Leerink Partnrs analyst J. Schwartz now expects that the cSeptember 23, 2024 | marketbeat.comBank of New York Mellon Corp Takes $1.33 Million Position in Applied Therapeutics, Inc. (NASDAQ:APLT)Bank of New York Mellon Corp bought a new position in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 283,793 shares of the company's stock,September 20, 2024 | marketbeat.comAssessing Applied Therapeutics (APLT): Unveiling the Reasons Behind a Buy RatingSeptember 19, 2024 | markets.businessinsider.comApplied Therapeutics (NASDAQ:APLT) Stock, Short Interest ReportSeptember 19, 2024 | benzinga.comCitigroup Boosts Applied Therapeutics (NASDAQ:APLT) Price Target to $11.00Citigroup increased their price objective on shares of Applied Therapeutics from $8.00 to $11.00 and gave the stock a "buy" rating in a report on Thursday.September 19, 2024 | marketbeat.comApplied Therapeutics (NASDAQ:APLT) Sees Large Volume Increase Following Analyst UpgradeApplied Therapeutics (NASDAQ:APLT) Sees Strong Trading Volume on Analyst UpgradeSeptember 19, 2024 | marketbeat.comApplied Therapeutics: AdCom Decision Takes Govorestat Approval A Step CloserSeptember 19, 2024 | seekingalpha.comApplied Therapeutics, Inc. (NASDAQ:APLT) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) have been assigned a consensus rating of "Buy" from the six research firms that are presently covering the stock, MarketBeat reports. Five investment analysts have rated the stock with a buy rating and one has assigned a strongSeptember 19, 2024 | marketbeat.comFed cuts rates by 50 basis points: Yahoo FinanceSeptember 18, 2024 | finance.yahoo.comApplied Therapeutics Shares Rise as Drug Continues with Priority ReviewSeptember 18, 2024 | marketwatch.comApplied Therapeutics Completes Late-Cycle Meeting With FDA Regarding NDA Review Of GovorestatSeptember 18, 2024 | markets.businessinsider.comApplied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder DrugSeptember 18, 2024 | finance.yahoo.comStock Traders Purchase High Volume of Call Options on Applied Therapeutics (NASDAQ:APLT)Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors bought 10,681 call options on the company. This represents an increase of approximately 2,011% compared to the average daily volume of 506 call options.September 18, 2024 | marketbeat.comWhy Applied Therapeutics Stock Is Skyrocketing TodaySeptember 18, 2024 | fool.comApplied Therapeutics (NASDAQ:APLT) Shares Down 4.1% Applied Therapeutics (NASDAQ:APLT) Shares Down 4.1%September 16, 2024 | marketbeat.comBuy Rating Affirmed for Applied Therapeutics: Strategic Positioning and Commercial Prospects of GovorestatSeptember 13, 2024 | markets.businessinsider.comApplied Therapeutics (NASDAQ:APLT) Shares Down 6.9% Applied Therapeutics (NASDAQ:APLT) Trading Down 6.9%September 10, 2024 | marketbeat.comApplied Therapeutics: Pushing Towards FDA ApprovalSeptember 5, 2024 | seekingalpha.comApplied Therapeutics (NASDAQ:APLT) Stock Price Down 5.3%Applied Therapeutics (NASDAQ:APLT) Trading Down 5.3%September 4, 2024 | marketbeat.comApplied Therapeutics to Participate in Upcoming Investor ConferencesSeptember 4, 2024 | finance.yahoo.comPeregrine Capital Management LLC Purchases Shares of 731,048 Applied Therapeutics, Inc. (NASDAQ:APLT)Peregrine Capital Management LLC purchased a new stake in shares of Applied Therapeutics, Inc. (NASDAQ:APLT - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 731,048 shares of the company's stock, valued at apAugust 31, 2024 | marketbeat.comCitigroup Increases Applied Therapeutics (NASDAQ:APLT) Price Target to $8.00Citigroup boosted their price target on Applied Therapeutics from $7.00 to $8.00 and gave the company a "buy" rating in a report on Tuesday.August 27, 2024 | marketbeat.com Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. APLT Media Mentions By Week APLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APLT News Sentiment▼0.100.54▲Average Medical News Sentiment APLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APLT Articles This Week▼83▲APLT Articles Average Week Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Prothena News Avid Bioservices News Dynavax Technologies News Rigel Pharmaceuticals News G1 Therapeutics News Puma Biotechnology News Ultragenyx Pharmaceutical News Immunovant News Organon & Co. News Rhythm Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APLT) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
